Search

everythinglearnresearchcommunity

for

Search:↓

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Type I interferons play a key role in the development of various skin diseases.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Skin organoids are a promising new model for studying human skin development and testing treatments.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Certain human skin cells marked by CD44 and ALDH are rich in stem cells capable of long-term skin renewal.

Suppressing certain hormones might help prevent prostate cancer.

New compounds may soon be tested to treat excessive hair growth in women.

Astaxanthin is a safe antioxidant that may improve heart, skin, eye health, and physical performance, and help manage chronic diseases.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Every elderly patient had at least one skin condition, often linked to other diseases, highlighting the need for integrated skin and general healthcare in the elderly.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.